These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10492668)

  • 21. Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance.
    Foote SJ; Galatis D; Cowman AF
    Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3014-7. PubMed ID: 2183221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Susceptibility of Plasmodium falciparum to the drugs used to treat severe malaria (quinine) and to prevent malaria (mefloquine, cycloguanil) in Comoros Union and Madagascar.
    Randrianarivelojosia M; Randrianasolo L; Randremanana RV; Randriamanantena A; Ratsimbasoa A; Rakotoson JD
    S Afr Med J; 2004 Jan; 94(1):47-51. PubMed ID: 14971233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [In vitro sensitivity of Plasmodium falciparum to anti-folinic agents (trimethoprim, pyrimethamine, cycloguanil): a study of 29 African strains].
    Basco LK; Le Bras J
    Bull Soc Pathol Exot; 1997; 90(2):90-3. PubMed ID: 9289260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Profile and evolution of the chemosusceptibility of falciparum malaria imported into France in 2000.
    Ralaimazava P; Durand R; Godineau N; Keundjian A; Jezic Z; Pradines B; Bouchaud O; Le Bras J
    Euro Surveill; 2002 Jul; 7(7):113-8. PubMed ID: 12631932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Point mutations in dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum isolates from Venezuela.
    Urdaneta L; Plowe C; Goldman I; Lal AA
    Am J Trop Med Hyg; 1999 Sep; 61(3):457-62. PubMed ID: 10497990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria.
    Peterson DS; Milhous WK; Wellems TE
    Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3018-22. PubMed ID: 2183222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polyclonal Plasmodium falciparum malaria in travelers and selection of antifolate mutations after proguanil prophylaxis.
    Färnert A; Tengstam K; Palme IB; Bronner U; Lebbad M; Swedberg G; Björkman A
    Am J Trop Med Hyg; 2002 May; 66(5):487-91. PubMed ID: 12201581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Why has the dihydrofolate reductase 164 mutation not consistently been found in Africa yet?
    Nzila A; Ochong E; Nduati E; Gilbert K; Winstanley P; Ward S; Marsh K
    Trans R Soc Trop Med Hyg; 2005 May; 99(5):341-6. PubMed ID: 15780340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transformation with human dihydrofolate reductase renders malaria parasites insensitive to WR99210 but does not affect the intrinsic activity of proguanil.
    Fidock DA; Wellems TE
    Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10931-6. PubMed ID: 9380737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malaria: use of restriction endonuclease digestion and mutation-specific PCR for antifolate resistance isolate detection.
    Kengne P; Ouédraogo JB; Zampan H; Veas F; Guiguemdé TR
    Parassitologia; 2003 Mar; 45(1):27-31. PubMed ID: 15270541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Point mutations in the dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum and resistance to sulfadoxine-pyrimethamine in Sri Lanka.
    Hapuarachchi HC; Dayanath MY; Bandara KB; Abeysundara S; Abeyewickreme W; de Silva NR; Hunt SY; Sibley CH
    Am J Trop Med Hyg; 2006 Feb; 74(2):198-204. PubMed ID: 16474070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The occurence of point mutations in the dihydrofolate reductase-thymidylate synthase (DHFR) gene in Thai isolates of Plasmodium falciparum.
    Lim PK; Looareesuwan S; Chindanond D; Saleh AM; Tan SK
    Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):525-8. PubMed ID: 10437950
    [No Abstract]   [Full Text] [Related]  

  • 33. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance.
    Plowe CV; Cortese JF; Djimde A; Nwanyanwu OC; Watkins WM; Winstanley PA; Estrada-Franco JG; Mollinedo RE; Avila JC; Cespedes JL; Carter D; Doumbo OK
    J Infect Dis; 1997 Dec; 176(6):1590-6. PubMed ID: 9395372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania.
    Mbugi EV; Mutayoba BM; Malisa AL; Balthazary ST; Nyambo TB; Mshinda H
    Malar J; 2006 Oct; 5():94. PubMed ID: 17076899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High Plasmodium falciparum resistance to chloroquine and sulfadoxine-pyrimethamine in Harper, Liberia: results in vivo and analysis of point mutations.
    Checchi F; Durand R; Balkan S; Vonhm BT; Kollie JZ; Biberson P; Baron E; Le Bras J; Guthmann JP
    Trans R Soc Trop Med Hyg; 2002; 96(6):664-9. PubMed ID: 12625147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular assays for surveillance of antifolate-resistant malaria.
    Kublin JG; Witzig RS; Shankar AH; Zurita JQ; Gilman RH; Guarda JA; Cortese JF; Plowe CV
    Lancet; 1998 May; 351(9116):1629-30. PubMed ID: 9620719
    [No Abstract]   [Full Text] [Related]  

  • 37. [Considering disparities in resistance of Plasmodium falciparum in Africa in chemoprevention decisions].
    Le Bras J; Durand R; di Piazza JP; Pradines B; Longuet C; Parzy D
    Presse Med; 1998 Sep; 27(28):1419-23. PubMed ID: 9793037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apparent absence of atovaquone/proguanil resistance in 477 Plasmodium falciparum isolates from untreated French travellers.
    Musset L; Pradines B; Parzy D; Durand R; Bigot P; Le Bras J
    J Antimicrob Chemother; 2006 Jan; 57(1):110-5. PubMed ID: 16319183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of an association between the ASN-108 mutation in the dihydrofolate reductase gene and in vivo resistance to sulfadoxine/pyrimethamine in Plasmodium falciparum.
    Rallón NI; Osorio LE; Giraldo LE
    Am J Trop Med Hyg; 1999 Aug; 61(2):245-8. PubMed ID: 10463674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a lead inhibitor for the A16V+S108T mutant of dihydrofolate reductase from the cycloguanil-resistant strain (T9/94) of Plasmodium falciparum.
    Yuthavong Y; Vilaivan T; Chareonsethakul N; Kamchonwongpaisan S; Sirawaraporn W; Quarrell R; Lowe G
    J Med Chem; 2000 Jul; 43(14):2738-44. PubMed ID: 10893311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.